fig11

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer

Figure 11. Drug resistance analysis. (A) Composite plot of bendamustine resistance; (B) Composite plot of apalutamide resistance; (C) Composite plot of dacomitinib resistance; (D) Composite plot of neratinib resistance; (E) Resistance bubble chart. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/